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summary 
The stems of Dracaena cambodiana have been investigated for antifungal constituents, 
resulting in the isolation of a new steroidal saponin dracagenin A (1) together with two known 
components 25S-namogenin B (2) and spriroconazole A (3). Their structures were elucidated on 
the basis of extensive spectroscopic analysis including 1D, 2D NMR and ESI MS. The isolated 
compounds were evaluated for their antifungal activities. 1 and 3 exhibited inhibitory activity 
against Aspergilus niger at the MICs of 50 μg/ml. No inhibition effects on F. oxysporum, S. 
cerevisiae and C. albicans have been found for the tested compounds. Interestingly, toxicity of 3 
towards several cancer cell lines has been demonstrated. The IC50 of 3 against Hep-2, Lu, and RD 
are 2.002, 4.727, and 4.029 μg/ml, respectively. 
Keywords: Dracaenaceae, Dracaena cambodiana, Steroidal saponin, Dracagenin A. 
 
I - INTRODUCTION 
Dracaena cambodiana (Dracaenaceae) is 
mostly distributed in the North of Vietnam. The 
plant has been found in ethnomedicine to treat 
menoschesis, ostealgia etc (Bich, 2006; Chi, 
1997; Loi, 2001). Investigations on the chemical 
constituents of the genus revealed that the 
spirosterol and steroidal saponin are among the 
major components (Gonzalez, 2004; Mimaki, 
1998). Interestingly, there has been no report on 
the phytochemical of D. cambodiana. On our 
continuing studies for antifungal agents, we 
have isolated a new steroidal saponin namely 
dracagenin A (1), one sprirosterol 25S-
namogenin B (2) and one known steroidal 
saponin spriroconazole A (3). The antifungal 
activities of these compounds were also 
described. 
II - MATERIALS AND METHODS 
General experiment procedures 
The 1H-NMR (500 MHz) and 13C-NMR 
(125 MHz) spectra were recorded on a Bruker 
AM500 FT-NMR spectrometer. Chemical shifts 
are referenced to δ using tetramethylsilan 
(TMS) as an internal standard. The Electron 
Spray Ionization (ESI) mass spectrum was 
obtained using an AGILENT 1100 LC-MSD 
Trap spectrometer. Column chromatography 
(CC) was performed on silicagel 230 - 400 mesh 
(0.040-0.063 mm, Merck) or YMC RP-18 resins 
(30-50 μm, FuJisilisa Chemical Ltd.). Thin layer 
chromatography (TLC) was performed on DC-
Alufolien 60 F254 (Merck 1.05715) or RP18 F254s 
(Merck) plates. 
Plant material  
The roots of D. cambodiana were collected 
in Hoabinh province, Vietnam in January 2006 
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and identified by Dr. Tran Huy Thai, Institute of 
Ecology and Biological Resources, VAST, 
Vietnam. An authentic sample was deposited at 
the Institute of Natural Products Chemistry, 
VAST, Vietnam. 
Extraction and isolation 
The dried roots of D. cambodiana (4 kg) 
were extracted with MeOH three times (7 days 
each time) and then concentrated under low 
pressure to obtain 150 g MeOH extract. The 
MeOH extract was suspended in water and 
partitioned with hexane, CHCl3 and BuOH to 
obtain n-hexane (60 g), CHCl3 (35 g), and 
BuOH (65 g) fractions. The CHCl3 fraction was 
then chromatographed on silicagel column 
eluting with CHCl3-MeOH gradient (from 10:1 
to 1:1 v/v) to give fractions C1 (16 g), C2 (11 g), 
and C3 (7 g). C1 fraction was chromatographed 
on a silicagel column using CHCl3-EtOAc (3:1) 
as eluent to give subfractions C3A (6.5 g), C3B 
(3.4 g), C3C (6.0 g). The C3C subfraction (6.0 
g) was chromatographed on a silica gel column 
using a CHCl3-MeOH (3:1 v/v) system as eluent 
yielded 2 (25 mg) as white powder. The BuOH 
fraction was chromatographed on silicagel 
column eluting with CHCl3-MeOH gradient 
(from 10:1 to 1:1 v/v) to obtain fractions B1 (25 
g), B2 (20 g), and B3 (12 g). B2 fraction showed 
the most active antifungal activity then selected 
for further isolation of bioactive compounds. 
The B2 fraction (20 g) was chromatographed on 
an YMC RP-18 column using a MeOH-H2O 
(2:1 v/v) system as eluent yielded 1 (18.5 mg) 
and 3 (9 mg) as white amorphous powder. 
 25S-Namogenin B (2): White powder, 
positive ESI-MS m/z: 447 [M+H]+, 429 [M+H-
H2O]
+, 411 [M+H-2H2O]
+; negative ESI-MS 
m/z: 445 [M-H]-; 1H-NMR (500 MHz, CDCl3) δ: 
3.46 (dd, J = 4.0, 11.5 Hz, H-1), 1.57/2.06 (m, 
H-2), 3.53 (m, H-3), 1.89/2.24 (m, H-4), 5.57 
(d, J = 5.5 Hz, H-6), 1.94/2.08 (m, H-7), 1.97 
(m, H-8), 1.59 (m, H-9), 1.60/2.11 (m, H-11), 
1.42/1.75 (m, H-12), 1.61/1.95 (m, H-15), 4.60 
(m, H-16), 2.29 (m, H-17), 0.94 (s, H-18), 1.07 
(s, H-19), 2.10 (m, H-20), 1.01 (d, J = 7.0 Hz, 
H-21), 1.94/2.02 (m, H-23), 1.40/2.11 (m, H-
24), 1.72 (m, H-25), 3.29 (d, J =2.5 Hz, H-26a), 
3.93 (d, J = 11.0 Hz, H-26b), 0.90 (d, J = 7.0 
Hz, H-27); 13C-NMR (125 MHz, CDCl3) δ: 77.7 
(C-1), 42.0 (C-2), 67.9 (C-3), 42.6 (C-4), 137.6 
(C-5), 125.5 (C-6), 26.2 (C-7), 35.7 (C-8), 43.7 
(C-9), 43.2 (C-10), 22.6 (C-11), 32.0 (C-12), 
44.0 (C-13), 87.6 (C-14), 39.4 (C-15), 81.9 (C-
16), 58.8 (C-17), 20.0 (C-18), 13.0 (C-19), 42.2 
(C-20), 14.5 (C-21), 110.0 (C-22), 26.1 (C-23), 
25.8 (C-24), 27.1 (C-25), 65.1 (C-26), 16.1 (C-
27). 
Spriroconazole A (3): White powder, 
positive ESI-MS m/z: 907 [M+Na]+; negative 
ESI-MS m/z: 883 [M-H]-; 1H-NMR (500 MHz, 
CDCl3) δ: 1.11/1.90 (m, H-1), 1.31/1.91 (m, H-
2), 3.66 (m, H-3), 2.29/2.47 (m, H-4), 5.40 (d, J 
= 5.0 Hz, H-6), 1.37/1.59 (m, H-7), 1.65 (m, H-
8), 0.98 (m, H-9), 1.54/1.63 (m, H-11), 
1.65/2.03 (m, H-12), 1.73 (m, H-14), 1.25/1.71 
(m, H-15), 4.01 (dd, J = 7.0, 8.0 Hz, H-16), 
0.85 (s, H-18), 1.07 (s, H-19), 2.11 (m, H-20), 
0.94 (d, J = 7.0 Hz, H-21), 1.70/2.03 (m, H-23), 
1.45/1.62 (m, H-24), 1.62 (m, H-25), 3.36/3.47 
(m, H-26), 0.81 (d, J = 6.5 Hz, H-27),  4.53 (d, 
J = 7.0 Hz, H-1Glc), 3.58 (t, J = 9.0 Hz, H-3 
Glc), 4.99 (d, J = 1.5 Hz, H-1 RhaI), 1.26 (d, J 
= 6.5 Hz, H-6 RhaI), 4.92 (d, J = 1.5 Hz, H-1 
RhaII), 1.28 (d, J = 6.5 Hz, H-6 RhaII); 13C-
NMR (125 MHz, CDCl3) δ: 38.6 (C-1), 30.8 (C-
2), 79.1 (C-3), 39.3 (C-4), 141.9 (C-5), 122.9 
(C-6), 32.8 (C-7), 33.3 (C-8), 51.5 (C-9), 38.0 
(C-10), 21.7 (C-11), 33.2 (C-12), 45.8 (C-13), 
53.1 (C-14), 32.1 (C-15), 90.6 (C-16), 91.3 (C-
17), 17.5 (C-18), 19.8 (C-19), 45.5 (C-20), 9.1 
(C-21), 111.0 (C-22), 32.5 (C-23), 29.4 (C-24), 
31.3 (C-25), 67.7 (C-26), 17.5 (C-27), Glc (1) 
100.2, (2) 97.4, (3) 88.4, (4) 70.5, (5) 77.5, (6) 
62.6, RhaI (1) 102.8, (2) 72.3, (3) 72.5, (4) 
73.6, (5) 70.1, (6) 17.8, RhaII (1) 103.9, (2) 
72.2, (3) 72.4, (4) 73.8, (5) 70.9, (6) 18.1. 
III - RESULTS AND DISCUSSION 
Bioassay guided fractionation led to the 
isolation of three bioactive components. 
Compound 1 was obtained as white amorphous 
powder, The ESI MS (positive mode) showed 
the pseudomolecular [M+Na]+ ion peak at m/z 
1085 (corresponding to the molecular formula 
C51H82O23). The 


























































































































Figure 1: Structures of 1-3 
 
51 signals, among which 27 were assigned to 
the aglycone, the remaining 24 signals were 
indicative of the presence of four hexoses due to 
two D-glucoses and two L-rhamnoses. The 
structure of the aglycone moiety was recognized 
to be penogenin (3β,17α-dihydroxyspirost-5en) 
by 1H- and 13C-NMR spectral analysis using 
connectivities observed in COSY, HSQC, and 
 505
HMBC. The 1H-NMR spectrum of 1 showed 
two three-proton singlet signals at δ 0.83 and 
1.07 and two three-proton doublet signals at δ 
0.91 (J = 7.5 Hz) and 1.00 (J = 6.5 Hz), which 
were characteristic of the spirostanol skeleton, 
as well as signals for four anomeric protons at δ 
4.54 (d, J =7.5 Hz), 4.37 (d, J = 7.5 Hz), 5.00 
(d, J = 1.5 Hz), 1.92 (d, J = 1.5 Hz). The salient 
features of this aglycone part were the 13C-NMR 
signals at δ 141.9 (C-5) and 122.6 (C-6), 
characteristic of Δ5-spirostene-type sapogenin. 
The proton coupling constant between H-25 and 
H-26ax (J = 11.5 Hz), and the 
13C-NMR shifts of 
the F-ring part (C-25/δ 38.5) gave an evidence 
for the C-25R configuration.
  
Table 1: NMR data of 1 
No. δCa,b δHa,c (J, Hz) HMBC (H to C) 
1 38.6 1.13 m; 1.90 m C-5 
2 30.7 1.62 m; 1.91 m  
3 79.1 3.65 m C-1 Glc 
4 39.3 2.30 m; 2.47 m C-2, C-5, C-6, C-10 
5 141.9   
6 122.6 5.40 d (5.5) C-8, C-10 
7 32.8 1.37 m; 1.68 m  
8 33.3 1.65 m  
9 51.5 0.97 m  
10 38.0   
11 21.7 1.49 m; 1.63 m  
12 33.2 1.59 m; 2.03 m  
13 45.7   
14 53.9 1.74 m  
15 32.0 1.31 m; 2.05 m C-15, C-17 
16 90.9 3.99 t (6.5)  
17 91.8   
18 17.5 0.83 s C-12, C-13, C-14, C-17 
19 19.8 1.07 s C-4, C-9 
20 45.9 2.16 m C-14, C-17, C-21, C-23 
21 9.0 0.91 d (7.5) C-17, C-20, C-22 
22 113.8   
23 41.0 1.69 m; 2.22 m C-24, C-25 
24 82.0 3.62 m  
25 38.5 1.67 m  
26 65.8 3.38 m; 3.53 m C-24, C-27 
27 13.5 1.00 d (6.5) C-24, C-26 
GlcI (1 → C3) 
1 100.2 4.54 d (7.5) C-3 
2 79.4 3.47 m  
3 88.4 3.60 m C-2 Glc, C-4, Glc 
4 70.6 3.40 m  
5 77.5 3.29 m  
6 62.6 3.70 m; 3.88 m  
RhaI (1 → 2Glc) 
1 102.8 5.00 d (1.5) C-2 Glc, C-3 Rha, C-5 Rha 
2 72.3 3.64 m  
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No. δCa,b δH
a,c (J, Hz) HMBC (H to C) 
3 72.5 3.88 m  
4 73.6 3.43 m  
5 70.1 4.10 m  
6 17.8 1.26 d (6.0)  
RhaII (1 → 3Glc) 
1 103.9 4.92 d (1.5) C-3 Glc, C-3 Rha’, C-5 Rha’ 
2 72.2 3.86 m  
3 72.4 3.66 m  
4 73.8  3.43 m  
5 70.9 3.95 m  
6 18.1 1.28 d (6.0)  
GlcII (1 → C24) 
1 106.0 4.37 d (7.5) C-24 
2 75.5 3.17 m  
3 78.1 3.39 m  
4 71.7 3.33 m  C-5 Glc’ 
5 77.7 3.31 m  
6 62.8 3.70 m; 3.88 m  
aMeasured in CD3OD, 
b125 MHz, c500 MHz, Chemical shift (δ) in ppm. 
 
The connection of the sugars part to C-3 of 
the aglycone was confirmed by the correlation 
of an anomeric proton (δH 4.54) and C-3 
position (δC 79.1) in the HMBC spectrum. This 
carbohydrate consisted of one disubstituted 
glucose and two terminal rhamnose moieties. 
The linkage positions of the sugars were 
determined by HMBC spectrum. Accordingly, 
the anomeric proton signal observed in 1H-NMR 
spectrum at δH 5.00 correlated with C-2 (δC 
79.4) of glucose, the anomeric proton signal 
observed in 1H-NMR spectrum at δH 4.92 
correlated with C-3 (δ 88.3) of glucose. 
Furthermore, the presence of two upfield signals 
of methyl protons at δ 1.26 (d, J = 1.5 Hz), and 
1.28 (d, J = 1.5 Hz) in its 1H-NMR spectrum 
confirmed that the two deoxyhexopyranose 
units were rhamnose moieties. The 
rhamnopyranosyl residues were shown to be 
terminal units as suggested by the absence of 
any glysosydation shift for their carbon 
resonances. The 2,3 distribution of the 
glucopyranosyl moiety was shown by downfield 
chemical shifts at δ 79.4 (C-2 GlcI) and 88.3 (C-
3 GlcI) in the 13C-NMR spectrum. The NMR 
data were in good agreement with literature data 
(Tepono, 2001; Yokosuka, 2002). 
The remaining sugar moiety was also 
determined by extensive spectroscopic studies. 
The strong downfield shift signal at C-24 (δ 
82.0) in 13C-NMR spectrum was indicative of 
the presence of one sugar moiety at this 
position. The correlation observed in HMBC 
spectrum between the anomeric proton (δH 4.37 
(d, J = 7.5 Hz)) and C-24 (δC 82.0) confirmed 
that one glucose unit connected to C-24 of the 
F-ring. By above evidence and comparison with 




were named as dracagenin A. This is the first 
report of this compound from the nature. 
Compound 2 was obtained as white powder. 
Inspecting the NMR data of 2 revealed that 2 
was a spirostane-type sterol. The NMR data of 2 
were similar to those of the aglycone of 1 except 
for the appearance of two hydroxyl group at C-1 
(δH 3.46 (dd, J = 4.0, 11.5 Hz)/ δC 77.7) and C-
14 (δC 87.6) and the upfield shifts of the signals 
of F-ring from C-23 to C-27. This evidence 
suggested to the 25S configuration of 2. The 
13C-NMR spectrum of 2 showed the upfield 
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shift of the oxygenated signal (δ 58.8) assigned 
to C-17 in 1. Therefore, C-17 was considered as 
a methine group. The spectroscopic data of 2 
were compared with those of 25S-namogenin B 
and found to match (Tran, 2001). By carried out 
the same methods on structure elucidation using 
spectroscopic evidence, compound 3 were 
determine to be spriroconazole A, which were 
isolated from D. manii, D. arborea, and 
Dioscorea bulbifera L.var sativa (Tepono, 
2001). 
The isolated compounds were evaluated for 
their antifungal activities. 1 and 3 exhibited 
inhibitory activity against Aspergilus niger at 
the MICs of 50 μg/ml. No inhibition effects on 
F. oxysporum, S. cerevisiae and C. albicans 
have been found for the tested compounds. 2 
was inactive against all tested fungi. 
Interestingly, toxicity of 3 towards several 
cancer cell lines has been demonstrated. The 
IC50 of 3 against Hep-2, Lu, and RD are 2.002, 
4.727, and 4.029 μg/ml, respectively. Thus, 1 
and 3 should be considered to be promising 
antifungal agents from D. cambodiana.  
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